|
The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: ---------- Life Science REIT PLC - real estate investment trust for UK properties leased to tenants in the life science sector - Portfolio valuation as at December 31 is £332.6 million, down 7.8% from the £360.6 million at June 30. Attributes the decline to outward yield shift across the portfolio. Says this is ‘in line with wider market trends, but particularly impacts certain assets within the portfolio which are experiencing higher ongoing vacancy levels.’ Calls the drop off in venture capital and second phase funding for life science companies ‘a particular drag’ on laboratory occupier demand across the Golden Triangle. Says Cambourne Park Science and Technology Campus see the most significant declines. Unaudited European Public Real Estate Association Net Tangible Assets at December 30 is £201.8 million, or 57.7 pence per share, down 13% from £232.1 million, or 66.3 pence per share, in June. Says the EPRA NTA decline is due to further drawdowns from its debt facility to fund the development pipeline assets, the benefits of which are not yet reflected in the portfolio valuation. The company will publish audited results for the year ended December 31 2025 in April. ---------- ValiRx PLC - life sciences company - Enters nine-month, evaluation and material transfer agreement with The Royal Institute for the Advancement of Learning/McGill University and The Institute for Research in Immunology, and Cancer - Commercialization of Research. The Canadian institutions will work with ValiRx subsidiary Inaphaea Biolabs Ltd to investigate a second generation, orally available, RNA Helicase inhibitor. During the evaluation period, any results generated will be owned by ValiRx. IRICoR will establish a subsidiary to commercialise evaluation results and background intellectual property. The IRICoR subsidiary will be granted an exclusive, worldwide sub-licensable license to any background IP. ValiRx has an option to license the evaluation results into IRICoR’s subsidiary for a pre-agreed equity holding. Additionally, the IRICoR subsidiary will seek external non-dilutive and dilutive funding. ValiRx and potentially other investors may provide up to £2 million in seed funding. Funding other than the seed funding shall dilute all shares pari passu, ValiRx says. Rights to the evaluation results will be given to the institutions should ValiRx elected not to proceed with the license for equity. ValiRx will then be entitled to a cash payment from IRICoR of 1.5x its total investment should the institutions out-license, sell or otherwise commercialise the technology. ---------- Sunrise Resources PLC - exploration and development of mineral projects in western US - Option period for the sale of its Hazen Project expires, as the optioner fails to exercise or extend the option. Sunrise will now take back control of the non-core project. Further information will be provided in due course. ---------- Amedeo Air Four Plus Ltd - investment company that buys, leases and sells aircraft - Emirates exercises option with Amedeo subsidiary AA4P Gamma Ltd. The option enables Emirates to redeliver the Airbus A380-861, serial number 187, in the minimum condition equivalent to ‘half-life’ together with a cash sum, as opposed to delivery in full-life condition. The cash sum will be calculated in accordance with agreed monetary compensation arrangements, on or prior to the lease expiry date of August 3 2027. Amedeo says it may still consider lease extension, sale or re-lease options for the Aircraft with Emirates or other counterparties. ---------- Zoyo Ltd - formerly Honye Financial Services Ltd, prior to reverse takeover - Says KSA Catalyst Group will serve as its advisor in the Middle East. KSA will assist with strategic market entry, local partnerships, regulatory navigation and commercial positioning, beginning in Saudi Arabia and the wider Gulf region. ‘The engagement is intended to support Zoyo’s broader growth strategy across digital assets, trading platforms, tokenisation and related financial technologies, and to accelerate the establishment of long-term relationships with regional partners and institutions,’ company says. ---------- Celsius Resources Ltd - Philippines-focused gold and copper producer - Appoints Grant Samuel Capital Advisory Pty Ltd as financial adviser to assist with finalising financing for the Maalinao-Caigutan-Biyog Copper-Gold Project, held under its Philippine affiliate, Makilala Mining Co Inc. Says this follows the receipt of financing proposals in view of the imminent completion of the MCB Definitive Feasibility Study. Additionally, engages Bardin Davis as a consultant to the board on matters of strategy, financing and project development. Davis was most recently the chief executive officer of Peak Rare Earths. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
